FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical psychology. The Spielberger scale questionnaire survey is conducted to determine the reactive and personal anxiety levels. Pulse rate (b, blows/min), the reactive anxiety (RA) and personal anxiety (PA) levels are evaluated by formulas, respectively: RA = (Xr-Mr)/σr; PA = (Xp-Mp)/σp, where: Xr, Xp is a total score of key answers, reactive and personal, respectively, Mr, Mp is an mean value, i.e. an arithmetic mean indicator, reactive and personal, respectively, σr; σp is a root-mean-square deviation, reactive and personal, respectively. The derived values are used to calculate the anxiety level (AL) by formula: AL = (RA+PA)/160+kb, where: 160 is a maximum total score by the Spielberger scale, k is a regression coefficient equal to 0.1. If the AL=6.0-8.0, the low anxiety level is diagnosed; the AL=8.01-11.0 shows the medium anxiety level; and the high anxiety level is indicated by the AL exceeding 11.01.
EFFECT: technique allows for a subjective rapid assessment of general anxious functional status of a patient which is supposed to be used for the selection of prospective follow-up care for the purpose of the prevention of development of acute mental disorders.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT, A PHARMACEUTICAL COMPOSITION, AN ACTIVE INGREDIENT OF THE PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING ANXIETY AND DEPRESSION IN THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2018 |
|
RU2702128C1 |
METHOD FOR PREDICTING PROTRACTED COURSE OF PANIC DISORDER | 2020 |
|
RU2749487C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANIC DISORDER AND ORGANIC ANXIOUS DISORDER IN CONNECTION WITH VASCULAR DISEASE OF THE BRAIN | 2021 |
|
RU2770734C1 |
METHOD OF AMPLITUDE RATIO DETECTED WITH RHEOENCEPHALOGRAM OF PATIENTS SUFFERING FROM ARTERIAL HYPERTONIA | 2006 |
|
RU2326593C1 |
METHOD OF CORRECTING PSYCHOLOGICAL STATE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS TREATMENT | 2015 |
|
RU2645117C2 |
METHOD OF PREDICTING PROGRESSION OF VIRAL HEPATITIS COURSE | 2009 |
|
RU2416362C2 |
METHOD FOR PREDICTION OF RISK OF FORMATION OF ORGANIC ANXIETY DISORDER | 2019 |
|
RU2712915C1 |
METHOD OF CORRECTION OF ANXIETY-DEPRESSIVE DISORDERS IN PATIENTS WITH SYSTEMIC CONNECTIVE TISSUE DISEASES | 2018 |
|
RU2703723C1 |
METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
METHOD OF PREDICTING EFFICIENCY OF TREATMENT WITH ADAPTOL IN WOMEN IN POSTMENOPAUSAL PERIOD WITH ARTERIAL HYPERTENSION | 2010 |
|
RU2459580C2 |
Authors
Dates
2010-10-27—Published
2009-07-21—Filed